Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Zanidatamab zovodotin by Zymeworks for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
Zanidatamab zovodotin is under clinical development by Zymeworks and currently in Phase I for Adenocarcinoma Of The Gastroesophageal Junction. According...
Data Insights
Zanidatamab zovodotin by Zymeworks for Colorectal Cancer: Likelihood of Approval
Zanidatamab zovodotin is under clinical development by Zymeworks and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase...